APA (7th ed.) Citation

Facon, T., Kumar, S. K., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., . . . Usmani, S. Z. (2023). Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma. Future oncology, 19(13), . https://doi.org/10.2217/fon-2023-0082

Chicago Style (17th ed.) Citation

Facon, Thierry, et al. "Plain Language Summary of the MAIA Study of Daratumumab Plus Lenalidomide and Dexamethasone for the Treatment of People with Newly Diagnosed Multiple Myeloma." Future Oncology 19, no. 13 (2023). https://doi.org/10.2217/fon-2023-0082.

MLA (9th ed.) Citation

Facon, Thierry, et al. "Plain Language Summary of the MAIA Study of Daratumumab Plus Lenalidomide and Dexamethasone for the Treatment of People with Newly Diagnosed Multiple Myeloma." Future Oncology, vol. 19, no. 13, 2023, https://doi.org/10.2217/fon-2023-0082.